Spin-offs?
- Thread starter Brigadier
- Start date
Sponsored Links
D
Deleted member 18243
The global effort has been one of the surprising things about this: how the majority of the world's population can pull together to achieve an, albeit misdirected, aim.
The real pandemics destroying the world are crime (particularly drugs) and islam. These are real enemies that we can see, not invisible particles. A global effort to get rid of those would improve everybody's lives immensely, and would be relatively easy to do.
D
durhamplumber
BennyMF says numb things as he craves attention and trys to get a reaction....Andy is just numb.
ah, you're talking about the Brexit campaign.
Sponsored Links
B
Brigade77
https://bnf.nice.org.uk/medicinal-forms/dexamethasone.html
I'll let you have that one . . . .
But it still isn't the answer to all of this nonsense is it?
you'd need to define the question first.
Not the answer, but a damned good thing.
The answer is vaccination. But that's for another thread, I don't want to drag Brigadiers one even further off course.
- Joined
- 1 Apr 2016
- Messages
- 13,609
- Reaction score
- 552
- Country
Yep. A case in point. They are beholden to their shareholders - if you think they are doing something wrong then you need to consider should they be regulated more or accept this is one face of capitalism.
https://www.theguardian.com/society/2006/jun/17/health.medicineandhealth
A major drug company is blocking access to a medicine that is cheaply and effectively saving thousands of people from going blind because it wants to launch a more expensive product on the market.
Ophthalmologists around the world, on their own initiative, are injecting tiny quantities of a colon cancer drug called Avastin into the eyes of patients with wet macular degeneration, a common condition of older age that can lead to severely impaired eyesight and blindness. They report remarkable success at very low cost because one phial can be split and used for dozens of patients.
But Genentech, the company that invented Avastin, does not want it used in this way. Instead it is applying to license a fragment of Avastin, called Lucentis, which is packaged in the tiny quantities suitable for eyes at a higher cost. Speculation in the US suggests it could cost £1,000 per dose instead of less than £10. The company says Lucentis is specifically designed for eyes, with modifications over Avastin, and has been through 10 years of testing to prove it is safe.
- Joined
- 1 Apr 2016
- Messages
- 13,609
- Reaction score
- 552
- Country
D
dontbelieveawordofit
There is a view that when a government or supra-governmental organisation pays somebody to develop a drug or treatment, the organisation paying for it should own the rights.
Seemingly this simple and reasonable step was omitted.
Seemingly this simple and reasonable step was omitted.
B
Brigade77
If you still need an example of how 'big pharma' consistently fails to deliver . . . .
The common cold.
You would think, with all they have at their disposal, they would have solved that one by now . . . !
The common cold.
You would think, with all they have at their disposal, they would have solved that one by now . . . !
Sponsored Links
